Vistagen therapeutics to participate in upcoming investor conferences in march

South san francisco, calif., march 16, 2021 (globe newswire) -- vistagen therapeutics (nasdaq: vtgn), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (cns) disorders, today announced that shawn singh, vistagen's chief executive officer, will participate in the following investor conferences in march:
VTGN Ratings Summary
VTGN Quant Ranking